Parkinson’s disease has been modeled based on the LRRK2-G2019S mutation seen in sporadic forms, either from carrier-patient-derived iPSC [41], or iPSC genetically engineered using CRISPR/Cas9 technology [42]. The gene discussed is LRRK2; the disease is Parkinson disease.